Bioelectronics Corp (BIEL)

[luke5516]

That’s always a valid concern when OTCs go on a run. However, I think a key point is that hardly any investors know about this. When FDA approval and Bauer come through (as the CEO and others at the company have suggested in interviews as highly likely), in my opinion this will climb. It’s hard to imagine too many financial advisers pitching a sub penny company, but it could be a very different story if this hits .01 or .10.